Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cynosure Inc (NASDAQ:CYNO)

Delayed Data
As of 12:14pm ET
 -0.02 / -0.05%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis, reduce the appearance of cellulite and treat toenail fungus. It offers single energy source systems as well as workstations that incorporate two or more different types of lasers or pulsed light technologies. It also offers multiple technologies and system alternatives at a variety of price points depending primarily on the number and type of energy sources included in the system. Its newer products are designed to be easily upgradeable to add additional energy sources and hand pieces, which provide its customers with technological flexibility as they expand their practices. The company was founded on July 10, 1991 and is headquartered in Westford, MA.

Contact Information

Cynosure, Inc.
5 Carlisle Road
Westford Massachusetts 01886
P:(978) 256-4200
Investor Relations:



Other institutional53.54%
Mutual fund holders44.23%
Individual stakeholders14.56%

Top Executives

Michael R. DavinChairman & Chief Executive Officer
Timothy W. BakerPresident, COO, CFO, Treasurer & Executive VP
Rafael SierraChief Technology Officer
Peter C. AnastosSecretary, Senior Vice President & General Counsel
David MackieExecutive Vice President-Operations